TM4SF4 is a diagnostic biomarker accelerating progression of papillary thyroid cancer via AKT pathway
The incidence of papillary thyroid cancer (PTC) has been steadily rising, though the underlying mechanism remains unclear. This study aims to elucidate the biological role of TM4SF4 in the PTC progression. Our differential expression analysis indicated that TM4SF4 was significantly upregulated in PT...
Saved in:
| Main Authors: | Lizhi Lin, Jialiang Wen, Tiansheng Xu, Yuhao Si |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Cancer Biology & Therapy |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/15384047.2024.2424570 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Membrane Proteins Involved in Epithelial-Mesenchymal Transition and Tumor Invasion: Studies on TMPRSS4 and TM4SF5
by: Semi Kim, et al.
Published: (2014-03-01) -
TGFBR3 inhibits progression of papillary thyroid cancer by inhibiting the PI3K/AKT pathway and EMT
by: Hanrong Zhang, et al.
Published: (2024-11-01) -
Deep metabolic phenotyping of humans with protein-altering variants in TM6SF2 using a genome-first approach
by: Helen Ye Rim Huang, et al.
Published: (2025-01-01) -
Efficient high-power 2.3 μm continuous-wave laser operation of diffusion-bonded composite YVO4/Tm:GdVO4 crystals
by: Xiaoxu Yu, et al.
Published: (2024-01-01) -
Hidden in Plain Sight: Incidental Diagnosis of Metastatic Papillary Thyroid Microcarcinoma Without Radiologically Apparent Thyroid Tumor
by: Natalie Rivera Vargas, MD, et al.
Published: (2025-01-01)